Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 41 - 50 of 93 results for "Sciences"

MSCI launches life sciences indices

KARREN VERGARA  |  THURSDAY, 22 APR 2021
... to virology and oncology. Royalty Pharma, which is in the business of acquiring pharmaceutical royalties in the life sciences industry, will provide information on medical conditions, clinical trials, therapies and technologies that may lead to breakthrough ...

Money does buy happiness: Research

ELIZA BAVIN  |  WEDNESDAY, 27 JAN 2021
... contrary, new research suggests money does in fact buy happiness. A study conducted by Proceedings of the National Academy of Sciences (PNAS) in the US found that while personal wellbeing does not increase above incomes of $75,000, emotional experience ...

Super-backed company develops COVID treatment

ALLY SELBY  |  WEDNESDAY, 30 SEP 2020
... this could help keep them safe," HESTA chief investment officer Sonya Sawtell-Rickson said. "Our investments in life sciences are supporting jobs and growth in the sector where HESTA members work, while making a positive contribution to their financial ...

VanEck to launch four new ETFs

ALLY SELBY  |  MONDAY, 24 AUG 2020
... Neiron said. Holdings in the new fund include healthcare leaders such as Lilly, Bristol-Myers Squibb, Resmed and Gilead Sciences, he said. Meanwhile, GOAT is a high conviction international equity portfolio of at least 50 attractively priced wide moat ...

Chi-X TraCRs added to specialist platform

ALLY SELBY  |  WEDNESDAY, 5 AUG 2020
... Zoom, protective healthcare equipment producer 3M, global payments giant Mastercard and pharmaceutical company Gilead Sciences. WealthO2 co-founder and managing director Shannon Bernasconi said the new low cost and innovative Chi-X solution would enable ...

Property winners, losers of COVID-19 crisis

ALLY SELBY  |  THURSDAY, 23 JUL 2020
... recommended solutions," he said. "These include data centers... However, we are also looking further into areas such as life sciences, bio-medical and industrial cold storage." Despite the heavy sell off in REITs in March and several macro forces still ...

Chi-X releases viral TraCRs stocks

ALLY SELBY  |  THURSDAY, 25 JUN 2020
... provider 3M, payments giant Mastercard, supermarket conglomerate Walmart and anti-viral pharmaceutical company Gilead Sciences. Following today's announcement, there are now 35 US listed companies available to Australian investors via Chi-X's TraCRs. ...

Behavioural tools to limit losses, fear

ALLY SELBY  |  THURSDAY, 14 MAY 2020
... long-term financial success. In a virtual conference held by Morningstar, the investment manager's global head of decision sciences Ryan Murphy said arming investors with the skills to limit behavioural biases can be especially helpful during a crisis. ...

Markets react as antiviral drug disappoints

ALLY SELBY  |  FRIDAY, 24 APR 2020
... flopped in human trials saw markets fall overnight. Originally reported by the Financial Times, the publisher said Gilead Sciences antiviral drug remdesivir did not reduce the coronavirus pathogen in bloodstreams, nor did it improve patients' conditions ...

Super smashes best-performing salaries list

KARREN VERGARA  |  MONDAY, 1 JUL 2019
... for specialised roles in the industry, the report said. Full-time workers in mathematics, statistics and information sciences were rewarded with a 44% salary increase over the period, earning $118,937 per annum on average. Teaching aides and special ...